Colorectal Carcinoma Antibody (Y94): sc-52798

Colorectal Carcinoma Antibody (Y94) is a mouse monoclonal IgG1 kappa light chain antibody that detects the Colorectal Carcinoma protein of human origin by enzyme-linked immunosorbent assay (ELISA). Anti-Colorectal Carcinoma antibody (Y94) is available as the non-conjugated form, providing researchers with a reliable tool for studying this significant health concern. Colorectal cancer, which encompasses malignant growths in the colon, rectum, and appendix, is the third most prevalent cancer and the second leading cause of cancer-related deaths in the Western world. Colorectal Carcinoma protein plays a crucial role in the development and progression of this disease, particularly as mutations in key genes such as APC, K-Ras, and p53 disrupt normal cellular regulation and lead to uncontrolled cell proliferation. Understanding the structure of Colorectal Carcinoma protein is vital, as insights into functional domains can reveal how these contribute to tumorigenesis. Specific domains characterize Colorectal Carcinoma protein′s structure, facilitating interactions with other cellular components and influencing pathways related to cell growth and apoptosis. Anti-Colorectal Carcinoma antibody (Y94) enables scientists to explore these interactions and the underlying mechanisms of colorectal cancer, ultimately aiding in the development of targeted therapies and improving early detection strategies.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

Colorectal Carcinoma Antibody (Y94) References:

1. Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis.  |  Breivik, J. and Gaudernack, G. 1999. Semin Cancer Biol. 9: 245-54. PMID: 10448112
2. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.  |  Roncucci, L., et al. 2000. Cell Prolif. 33: 1-18. PMID: 10741640
3. Initiation of colorectal cancer: where do the two hits hit?  |  Komarova, NL. and Wang, L. 2004. Cell Cycle. 3: 1558-65. PMID: 15611641
4. Meat consumption and risk of colorectal cancer.  |  Chao, A., et al. 2005. JAMA. 293: 172-82. PMID: 15644544
5. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials.  |  Mosolits, S., et al. 2005. Expert Rev Vaccines. 4: 329-50. PMID: 16026248
6. Crypt dynamics and colorectal cancer: advances in mathematical modelling.  |  van Leeuwen, IM., et al. 2006. Cell Prolif. 39: 157-81. PMID: 16671995
7. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.  |  Winawer, SJ., et al. 1993. N Engl J Med. 329: 1977-81. PMID: 8247072
8. Molecular biology of colorectal cancer.  |  Gryfe, R., et al. 1997. Curr Probl Cancer. 21: 233-300. PMID: 9438104
9. Diet and the prevention of cancer.  |  Cummings, JH. and Bingham, SA. 1998. BMJ. 317: 1636-40. PMID: 9848907